Delivery Order SPE2DB20D1100-SPE2DB23FD6R0

Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $232
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This delivery order for voriconazole 200 mg tablets was awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp on October 5, 2023. The order has a potential value of $212 and requires delivery of the pharmaceutical products by October 6, 2023. This firm fixed price order was issued under an existing prime vendor contract vehicle and has no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where Amerisourcebergen's corporate...
The Defense Logistics Agency awarded a $1,876.74 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561824278, 75mL vials of the antifungal medication voriconazole at 40mg/mL. As the prime contractor, Amerisourcebergen will fulfill the order from its Conshohocken, Pennsylvania facility. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely procures pharmaceuticals and medical supplies to support Department of Defense...
This delivery order for $386 worth of voriconazole 200 mg vials was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania. The order is for delivery by October 12, 2023 under a firm fixed price contract vehicle. No set-aside designation was applied to this order for pharmaceutical products, which will support the Defense Logistics Agency's mission to provide medical supplies to the U.S. military. Amerisourcebergen Drug Corp will serve as...
This delivery order for $1,140.80, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for 4562428398 units of the antifungal medication voriconazole in 200 mg vials. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania, with completion by October 11, 2023. No set-aside designation was used for this award made under an unspecified existing contract vehicle. The Defense Logistics Agency supports America's armed forces by...
This delivery order for $2,311.20, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for 4562449005 vials of the antifungal medication voriconazole at 200 mg each. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania, with completion by October 12, 2023. No set-aside designation was used for this award made under an unspecified existing contract vehicle. The Defense Logistics Agency supports America's armed forces by...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $3,683.31 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for 4,564,274,187 units of the pharmaceutical product VORICONAZOLE 200 MG TABLET 30S. This delivery order was issued against an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,730,842 vials of the pharmaceutical drug voriconazole 200 mg. The $2,445.98 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) on May 28, 2024, with an ultimate completion date of May 29, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceuticals and medical supplies to the U.S. federal...
This is a $125,122.11 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The order is for the provision of 4,538,530,421 units of the pharmaceutical product VORICONAZOLE 200MG 30S. The contract has a completion date of July 31, 2017 and was awarded on July 3, 2017. No set-aside designation was used for this award. AmerisourceBergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VORICONAZOLE 200 MG TABLET 30S. The contract has a firm fixed price of $6,045.67 and a completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which...
The Defense Logistics Agency awarded a $333,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561702362, which is 200mg vials of the antifungal medication VFEND IV. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 4-7, 2023. This delivery order was awarded under an existing DLA contract vehicle to supply pharmaceutical products in support of Department of Defense health...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD6R0
    Delivery Order

The Defense Logistics Agency awarded a $231,900 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562205137 Voriconazole 200 mg vials. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four-day period concluding on September 19, 2023. No subcontractors or set aside designations were identified. The order fulfills DLA's ongoing requirements for this antifungal medication as it supports military treatment facilities in providing healthcare services.

Generated 12/18/23, 11:16 AM